Page 4 - Clinical Trials

Experts recommend Covaxin for phase 2/3 trials on those aged 2-18 year

Bharat Biotech's Covid-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said

Bharat Biotech's Krishna Ella wants maximum price for its vaccine

Says the company would like to recover the costs incurred in clinical trials, and other things and reinvest the money into R&D to be ready for future pandemics

Clinical trials on India's first mRNA Covid-19 vaccine to begin soon

Gennova's Covid vaccine candidate HGCO19 would remain stable at 2 to 8 degree Celsius temperature

Covid-19 vaccine: Bharat Biotech's Covaxin goes off clinical trial mode

Expert panel recommends emergency use authorisation

Russian, Chinese hacking groups target pharma companies for Covid-19 data

Singapore-based cyber intelligent firm Cyfirma says 15 active hacking campaigns are underway; US, UK and Japan among a slew of other nations also on cybercriminals' target list

All data pertaining to Covid vaccine trials should be made public: PMSF

Progressive Medicos and Scientists Forum said the Clinical Trial (PMSF) Phase 3 data should be evaluated in a transparent manner as and when available for India for both vaccines

Covid-19 vaccine: Bharat Biotech completes recruitment for phase 3 trials

More than 5,000 people have been given both shots of the vaccine; efficacy data around March

India Coronavirus Dispatch: Nod to Covaxin raises many eyebrows

Other vaccines being developed in India, dangerous conspiracy theories, private hospitals keen on jumping in-news relevant to India's fight against Covid-19

Zydus gets DCGI nod for conducting phase-3 clinical trials of ZyCoV-D

Company to initiate trials with around 30,000 volunteers

CDSCO panel to reconvene on Jan 1 to consider vaccine's emergency use

An expert panel in the Central Drugs Standard Control Organisation that met on Wednesday to consider emergency use authorisation applications will reconvene on Jan 1 to deliberate on the matter.

Biotech's Covaxin shows good results in clinical trials: Research paper

Covaxin, being developed in collaboration with the Indian Council of Medical Research and the National Institute of Virology, is now undergoing phase-3 trials

Fortune or foresight? AstraZeneca, Oxford stories clash on Covid-19 vaccine

The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose

DCGI reassures all protocols being followed in Serum's clinical trials

The ethics committee has seven members, including a chairperson who has to be from outside the institution where the trial is being conducted.

Pfizer vaccine not coming to India soon as trials yet to be conducted

Pfizer has not yet applied for holding clinical trials on Indian volunteers

Bengal's Firhad Hakim becomes second minister to take 'Covaxin' trial shot

The trial, which started at the city''s ICMR-National Institute of Cholera and Enteric Diseases (NICED), was inaugurated by state Governor Jagdeep Dhankhar

Israel to start human trials of Covid-vaccine 'Brilife' by October-end

The press release did not specify as to how long the human trials are likely to take and by when the vaccine would be ready for use

Panel urges granting Dr Reddy's permission for Russia vaccine phase 2 trial

The SEC had on October 5 asked the firm to re-apply stating it will have to conduct both phase 2 and 3 clinical trials and cannot directly hold phase 3 trial for the vaccine in India

Dr Reddy's: Progress in Covid vaccine trials to boost firm's growth outlook

Good momentum in US and domestic sales, along with Covid-19 treatment portfolio is already driving analysts to upgrade earnings estimates

Emergency use authorisation for Covid vaccine to depend on trial data: Govt

On the issue of how the government plans to roll out the Covid-19 vaccine, he said that it is anticipated that supplies of vaccines would be available in limited quantities in the beginning

Dr Reddy's asked to re-submit Russian vaccine phase-3 trial application

Health Secy says a vaccine should be available in first quarter of next year if everything goes according to plan